abstract |
This invention encompasses methods for the inhibition of a physiological disorder associated with amyloidogenic proteins, which method comprises administering to a human in need thereof an effective amount of a compound of Formula I n n n wherein R 1 and R 3 are independently hydrogen, n n n n n wherein Ar is optionally substituted phenyl; n R 2 is selected from the group consisting of pyrrolidine, hexamthylenemino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof. |